Discover trends, market shifts, and competitive outlooks for the plasma fractionation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Plasma Fractionation Market, and What Factors Will Drive It?

Recent years have seen robust growth in the plasma fractionation market size. This market is expected to expand from $31.42 billion in 2024 to $34.44 billion in 2025, registering a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this historical growth include an increased prevalence of hemophilia and immunodeficiency disorders, a rising aging population, an escalating demand for immunoglobulins, an expansion in the number of plasma collection centers, and an increase in surgical procedures.

In the upcoming years, the plasma fractionation market size is projected to experience a significant increase, with an expectation of reaching $51.56 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The expected growth during this forecast period can be linked to increased global health care spending, more uses of plasma-derived medical products, enhanced attention to research and development, the need for plasma in addressing neurological conditions, and the expansion of plasma fractionation facilities. Key trends for the period under prediction include advancements in fractionation technologies, a shift to albumin and immunoglobulin treatments, heightened demand for specialty plasma products, an emphasis on pathogen inactivation technologies, and strategic alliances and partnerships in the plasma industry.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Are the Core Market Drivers Propelling Growth in the Plasma Fractionation Industry?

The growth of the plasma fractionation market is anticipated to be driven by the escalating incidence of chronic illnesses. Chronic diseases are defined as conditions that persist for a year or more and necessitate continual medical intervention. Examples include heart disease, cancer, and diabetes. Providing access to plasma products for chronic disease patients minimizes morbidity, enhances quality of life, and is cost-effective, resulting in a surge in plasma fractionation demand. For example, a report by the US-based National Library of Medicine published in January 2023 stated that the population aged 50 and above experiencing one or several chronic diseases is estimated to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Consequently, the healthcare analytical testing service market is being fueled by the rising prevalence of chronic diseases. Hence, the increase in chronic diseases across all age groups is predicted to fuel the growth of the plasma fractionation market.

How Is the Plasma Fractionation Market Segmented?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Which Regions Are Driving the Next Phase of the Plasma Fractionation Market Growth?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Plasma Fractionation Industry?

Leading corporations in the industry are implementing innovative technologies like high-tech facility processes that convert donated human plasma to essential medicines. These advancements augments the process’s efficiency and safety. For instance, in March 2023, German-based firm, CSL Behring inaugurated a new plasma fractionation facility, worth $470 million. This cutting-edge facility enhances the efficiency and safety of plasma processing, ensuring the production of superior quality and more dependable medicines. The new facility increases the availability of these vital medicines, thus addressing the rising demand and ensuring an increased number of patients have access to life-saving treatments. The incorporation of advanced automation and self-cleaning systems minimizes contamination risks and enriches the overall hygiene standards, thus improving patient safety.

View the full report here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

How Is the Plasma Fractionation Market Defined and What Are Its Core Parameters?

Plasma fractionation refers to the process of integrating manufacturing procedures to isolate the crude fractions that are then refined into specific medicinal products, in a sequential and integrated manner.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model